Loblaw buys into telemedicine with $75-million Maple stake


The retailer bought into Maple, a Toronto telemedicine provider, after its Shoppers Drug Mart chain partnered with the company to offer virtual consultations as COVID-19 spread throughout Canada. (The Logic)

Read this article for free

By entering your e-mail you consent to receiving commercial electronic messages from The Logic Inc. containing news, updates, offers or promotions about The Logic Inc.’s products and services. You can withdraw your consent at anytime. Please refer to our privacy policy or contact us for more details.

Already a subscriber?

Talking point: An industry source told The Globe and Mail the retailer purchased 20 to 25 per cent of Maple, which has a staff of 70 and annualized revenue of about $25 million. Shoppers president Jeff Leger said telemedicine “really became a critically important way of accessing care” during the pandemic and believes “there is a meaningful change, a tipping point in terms of how health care is accessed in Canada.” Loblaw started investing in health care with the purchase of Shoppers in 2014, and more recently the $170-million purchase of electronic-medical-record firm QHR in 2016.